Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab ; volume:27 ; number:1 ; day:4 ; month:11 ; year:2022 ; pages:61-74 ; date:1.2023
Molecular diagnosis & therapy ; 27, Heft 1 (4.11.2022), 61-74, 1.2023
- Creator
-
Cammett, Tobin J.
Garlo, Katherine
Millman, Ellen E.
Rice, Kara
Toste, Catherine M.
Faas, Susan J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40291-022-00620-3
- URN
-
urn:nbn:de:101:1-2405130901164.896253085821
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cammett, Tobin J.
- Garlo, Katherine
- Millman, Ellen E.
- Rice, Kara
- Toste, Catherine M.
- Faas, Susan J.
- SpringerLink (Online service)
Other Objects (12)
Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome
Thrombotic microangiopathy (TMA) associated with pregnancy: role of the clinical laboratory in differential diagnosis
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review
Thrombotic Microangiopathy in the Renal Allograft : Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
Corrigendum: Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis
A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome – a case report
TMA
TMA
Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome
Thrombotic microangiopathy (TMA) associated with pregnancy: role of the clinical laboratory in differential diagnosis
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review
Thrombotic Microangiopathy in the Renal Allograft : Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
Corrigendum: Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis
A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome – a case report
TMA
TMA
Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome
Thrombotic microangiopathy (TMA) associated with pregnancy: role of the clinical laboratory in differential diagnosis
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review
Thrombotic Microangiopathy in the Renal Allograft : Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
Corrigendum: Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis
A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome – a case report
TMA